MENA emerging as trial destination says ClinTec CEO
b'Improving healthcare infrastructure across the region and a large treatment-na\\xefve patient population makes the Middle East and North Africa (MENA) an increasingly attractive destination for drug trials says ClinTec CEO Rabinder Buttar.'